Pharmacologic Inhibition of JAK1/2 Potentiates Aminoglycoside-Induced Ototoxicity. [PDF]
Fleegel J +4 more
europepmc +1 more source
Distortion product otoacoustic emission (DPOAE) reveals hearing loss up to 16 kHz in pediatric chemotherapy patients. [PDF]
Hecker DJ +11 more
europepmc +1 more source
Pharmacotherapeutic Interventions for Sensorineural Hearing Loss: A Scoping Review. [PDF]
Mavandi M +6 more
europepmc +1 more source
Carboplatin May Be an Effective and Tolerable Treatment Option for Platinum-Sensitive Pancreatic Cancer Patients With Pre-existing Neuropathy. [PDF]
Yoo A, Galvet J, Kim S, Choy A, King D.
europepmc +1 more source
Rate of Hearing Loss in Platinum-Naïve Patients Receiving Immune Checkpoint Inhibitors. [PDF]
Brooks KA +11 more
europepmc +1 more source
Bortezomib-Induced Sensorineural Hearing Loss May Be Reversible with Intratympanic Dexamethasone. [PDF]
Peláez Casillas N +4 more
europepmc +1 more source
Eleutheroside E alleviates cisplatin-induced ototoxicity by down-regulating MAPK/NF-κB/NLRP3 signaling pathway and inhibiting cochlear cell pyroptosis. [PDF]
Zhang Y +12 more
europepmc +1 more source
Preliminary Evaluation of an Injectable Therapeutic for Cisplatin Ototoxicity Using Neuronal SH-SY5Y Cells. [PDF]
Hong M, Kedeshian K, Hoffman L, Kita A.
europepmc +1 more source
Navigating the Genetic Risk of Chemotherapy-Induced Hearing Loss in the Stria Vascularis. [PDF]
Lazetic T +4 more
europepmc +1 more source
Experimental and Clinical Approaches to Preventing Aminoglycoside-Induced Ototoxicity: A Scoping Review. [PDF]
Zadrożniak M +3 more
europepmc +1 more source

